Equity
€218,576 ▲ 22.7%
IMPULSE BIO paid out €10,000 in dividends. That is 20% of the 2025 profit.
IMPULSE BIO
Lifetime
4 annual accounts with figures on one time axispeak €179,882 (2023)
€119,924▲ 5.6%
peak €178,335 (2023)
€50,455▲ 21.3%
peak €218,576 (2025)
€218,576▲ 22.7%
€289,623▲ 382%
Board1 name since 2021
1 director
Documentsfilings and deeds
02-07-202629 days before the deadline
2025micro format
Dividend €10,000Equity from €178,122 to €218,576Debts from €60,112 to €289,623Investments €258,456
Key points
from the 2025 annual accountsTurnover
≈ €200,000 estimated
The micro format states no turnover.
Securities
€120,000
Mortgages, new in 2025. 54.9% of equity · not in the 2024 accounts.
Investments
€258,456 49.7 × depreciation
Green is investment, beige is depreciation.
Filings
4 annual accounts 3 late
The 2023 accounts came latest: 92 days after the end of the period.
Starting capital
€3,000 100 shares
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 3,135 companies had the same profile as IMPULSE BIO has now. Each dot stands for 8 companies, two years later.
97.0%
were still trading
2.1%
stopped another way
0.8%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,135 companies, not a prediction for IMPULSE BIO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0777558829
Incorporation
Founding capital of €3,000, 100 shares · Founder: (comparant) · Appointment: (director) · published on 24-11-2021 · Gazette deed
First establishment
Rue de la Douix 22, Esneux
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| IMPULSE BIO Esneux | €508,199 | €119,924 | 43.0% | - |
| JOSE LOPEZ CONSULTING Liège | €468,338 | €122,889 | 84.7% | - |
| NICK BRAUN Eupen | €577,155 | €116,083 | 28.5% | - |
| CPEGF Herstal | €579,958 | €133,448 | 18.0% | - |
| BeVet Services Saint-Ghislain Wanze | €428,487 | €131,636 | 95.1% | 0.6 |
| DPH CONSULTING Chaudfontaine | €467,962 | €147,886 | 97.0% | - |
| PHARMA AND CCS CONSULTING Chaudfontaine | €456,254 | €148,725 | 90.5% | - |
These companies have the same main activity as IMPULSE BIO: business and other management consultancy (NACE 70200). They are comparable in size and age: total assets between €428,000 and €580,000, founded between 2021 and 2022.
Official details
Source: KBO- Status
- Active since 22-11-2021Normal situation
- Activity
- Business and other management consultancyNACE 70200and 1 other
- Establishment unit
- 2.326.104.8374130 Esneux, since 22-11-2021
- Financial year end
- 31 December
- Peppol
- Reachable since 13-05-2025
Annual accounts 2025
- €508,199▲ 113%
- Filing
- Filed on 02-07-2026, 29 days before the end of the filing period
Insights on IMPULSE BIO
IMPULSE BIO files the micro format. That format states no turnover. The gross margin rose from €69,067 in 2022 to €119,924 in 2025.
The balance sheet grew most in 2025 through fixed assets.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about IMPULSE BIO
- What is the company number of IMPULSE BIO?
- The company number of IMPULSE BIO is 0777.558.829. The VAT number is the same number with BE in front: BE 0777.558.829.
- Where is IMPULSE BIO based?
- The registered office is at Rue de la Douix 22, 4130 Esneux.Company details
- What does IMPULSE BIO do?
- According to the KBO register, the main activity is business and other management consultancy (NACE 70200).
- What is the legal form of IMPULSE BIO?
- IMPULSE BIO is a private limited company (BV).
- When was IMPULSE BIO founded?
- IMPULSE BIO was founded on 22-11-2021.
- Is IMPULSE BIO still active?
- Yes, IMPULSE BIO is an active enterprise in the KBO register.
- What is the turnover of IMPULSE BIO?
- The turnover in financial year 2025 is ≈ €200,000. This figure is estimated from the gross margin of €119,924 and 109 comparable companies (NACE 70200). It probably lies between €170,000 and €240,000.Financials
- Is IMPULSE BIO profitable?
- In financial year 2025, IMPULSE BIO made a profit of €50,455.
- Where can I find the annual accounts of IMPULSE BIO?
- IMPULSE BIO filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of IMPULSE BIO due?
- IMPULSE BIO must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.